Participants with hepatic impairment must have been on a stable dose of medication or treatment regimen (e.g., no new medications and no changes to current medications within 14 days of screening) and were excluded if they had clinical signs of acute hepatitis, records of biliary obstruction or other causes of hepatic impairment not related to parenchymal disorders or diseases, a history of hepatic encephalopathy Grade 3 or presence of hepatic encephalopathy Grade 2, gastroesophageal varices not managed according to standard of care for patients with cirrhosis or with bleeding within 90 days prior to screening, acute or exacerbation of chronic liver failure or history of liver transplantation
Preclinical studies have demonstrated that GLP-1R agonists can reduce the accumulation of amyloid plaques, a hallmark of Alzheimer's disease, and improve synaptic function
Unlike oral semaglutide, tirzepatides larger molecular size and chemical modifications currently pose significant challenges for the development of an effective oral formulation," Dr
The provider then finalizes the care plan and sends prescriptions to the compounding pharmacy
430,431 Importantly, PCD requires preprocedural planning of the puncture site and access path under imaging guidance to achieve effective multi-tract or bridging drainage